Highest-scoring questions on the site.
Numbers first: SGN · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Details up front: TRIUMPH-1 · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
The particulars: Hangzhou · South Africa. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The specifics, since they change the answer: SURPASS-3 · survodutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret…
For reference: peptide mapping · ecnoglutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
For reference: MKM · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I suspect the usual explanation for this is wrong, or at least incomplete.…
I have the full paper rather than the abstract, and the supplementary appendix. I can parse the result. I am less sure what it licenses me to conclude. I have…
Details up front: mazdutide · sixteen weeks · minus 20 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a…
What I have: 30 mg · retatrutide. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would still…
For reference: vomiting · ecnoglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
Numbers first: racemisation · dulaglutide · 40 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
For reference: SELECT · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
The particulars: a 31G needle · survodutide · 8 mg/mL. I am trying to choose between two options that are usually discussed as though only one exists. I am not…
Numbers first: Changsha · Ireland. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Details up front: albumin-to-creatinine ratio · sixteen weeks · tirzepatide. I have a result I cannot explain, and I would rather diagnose it than guess. I have…
What I have: 30 mg · six weeks · fatigue. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
This is my second independent submission on material from the same supplier. I can find plenty of assertions about this and almost no reasoning, which is usually a…
What I have: 98.2% · Janoshik · 97.9% · Medutest. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I have: mazdutide · room temperature. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
Details up front: a 0.3 mL insulin syringe · 40 mg · 2 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay…
What I have: a GLP-1 receptor agonist · sixteen weeks · 30 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone…
What I have: 99.4% · Janoshik · 97.1%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the…
For reference: 98.4% · survodutide. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator because…